<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1-3.dtd?><?SourceDTD.Version 1.3?><?ConverterInfo.XSLTName jats2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id><journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id><journal-id journal-id-type="publisher-id">ijms</journal-id><journal-title-group><journal-title>International Journal of Molecular Sciences</journal-title></journal-title-group><issn pub-type="epub">1422-0067</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">8835302</article-id><article-id pub-id-type="doi">10.3390/ijms23031168</article-id><article-id pub-id-type="publisher-id">ijms-23-01168</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Deep Functional Profiling of Wild Animal Microbiomes Reveals Probiotic <italic toggle="yes">Bacillus pumilus</italic> Strains with a Common Biosynthetic Fingerprint</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Baranova</surname><given-names>Margarita N.</given-names></name><xref rid="af1-ijms-23-01168" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-8620-6998</contrib-id><name><surname>Kudzhaev</surname><given-names>Arsen M.</given-names></name><xref rid="af1-ijms-23-01168" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Mokrushina</surname><given-names>Yuliana A.</given-names></name><xref rid="af1-ijms-23-01168" ref-type="aff">1</xref><xref rid="af2-ijms-23-01168" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-2242-2127</contrib-id><name><surname>Babenko</surname><given-names>Vladislav V.</given-names></name><xref rid="af3-ijms-23-01168" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1966-8452</contrib-id><name><surname>Kornienko</surname><given-names>Maria A.</given-names></name><xref rid="af3-ijms-23-01168" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Malakhova</surname><given-names>Maja V.</given-names></name><xref rid="af3-ijms-23-01168" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Yudin</surname><given-names>Victor G.</given-names></name><xref rid="af4-ijms-23-01168" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name><surname>Rubtsova</surname><given-names>Maria P.</given-names></name><xref rid="af2-ijms-23-01168" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6987-8119</contrib-id><name><surname>Zalevsky</surname><given-names>Arthur</given-names></name><xref rid="af1-ijms-23-01168" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5603-5371</contrib-id><name><surname>Belozerova</surname><given-names>Olga A.</given-names></name><xref rid="af1-ijms-23-01168" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Kovalchuk</surname><given-names>Sergey</given-names></name><xref rid="af1-ijms-23-01168" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Zhuravlev</surname><given-names>Yuriy N.</given-names></name><xref rid="af4-ijms-23-01168" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name><surname>Ilina</surname><given-names>Elena N.</given-names></name><xref rid="af3-ijms-23-01168" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Gabibov</surname><given-names>Alexander G.</given-names></name><xref rid="af1-ijms-23-01168" ref-type="aff">1</xref><xref rid="af2-ijms-23-01168" ref-type="aff">2</xref><xref rid="c1-ijms-23-01168" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0384-6568</contrib-id><name><surname>Smirnov</surname><given-names>Ivan V.</given-names></name><xref rid="af1-ijms-23-01168" ref-type="aff">1</xref><xref rid="af2-ijms-23-01168" ref-type="aff">2</xref><xref rid="c1-ijms-23-01168" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-2220-0452</contrib-id><name><surname>Terekhov</surname><given-names>Stanislav S.</given-names></name><xref rid="af1-ijms-23-01168" ref-type="aff">1</xref><xref rid="af2-ijms-23-01168" ref-type="aff">2</xref><xref rid="c1-ijms-23-01168" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Schl&#x000fc;ter</surname><given-names>Hartmut</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-ijms-23-01168"><label>1</label>Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, 117997 Moscow, Russia; <email>baranova@ibch.ru</email> (M.N.B.); <email>kudzhaev_arsen@mail.ru</email> (A.M.K.); <email>yuliana256@mail.ru</email> (Y.A.M.); <email>aozalevsky@gmail.com</email> (A.Z.); <email>o.belozyorova@gmail.com</email> (O.A.B.); <email>xerx222@gmail.com</email> (S.K.)</aff><aff id="af2-ijms-23-01168"><label>2</label>Department of Chemistry, Lomonosov Moscow State University, 119991 Moscow, Russia; <email>mprubtsova@gmail.com</email></aff><aff id="af3-ijms-23-01168"><label>3</label>Federal Research and Clinical Centre of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435 Moscow, Russia; <email>daniorerio34@gmail.com</email> (V.V.B.); <email>manja_k@list.ru</email> (M.A.K.); <email>maja_m@mail.ru</email> (M.V.M.); <email>ilinaen@gmail.com</email> (E.N.I.)</aff><aff id="af4-ijms-23-01168"><label>4</label>Federal Scientific Center of the East Asia Terrestrial Biodiversity, Far-Eastern Branch of Russian Academy of Science, 690022 Vladivostok, Russia; <email>vgyudin@rambler.ru</email> (V.G.Y.); <email>zhuravlev@biosoil.ru</email> (Y.N.Z.)</aff><author-notes><corresp id="c1-ijms-23-01168"><label>*</label>Correspondence: <email>gabibov@ibch.ru</email> (A.G.G.); <email>smirnov@ibch.ru</email> (I.V.S.); <email>sterekhoff@gmail.com</email> (S.S.T.)</corresp></author-notes><pub-date pub-type="epub"><day>21</day><month>1</month><year>2022</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2022</year></pub-date><volume>23</volume><issue>3</issue><elocation-id>1168</elocation-id><history><date date-type="received"><day>25</day><month>11</month><year>2021</year></date><date date-type="accepted"><day>17</day><month>1</month><year>2022</year></date></history><permissions><copyright-statement>&#x000a9; 2022 by the authors.</copyright-statement><copyright-year>2022</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>The biodiversity of microorganisms is maintained by intricate nets of interactions between competing species. Impaired functionality of human microbiomes correlates with their reduced biodiversity originating from aseptic environmental conditions and antibiotic use. Microbiomes of wild animals are free of these selective pressures. Microbiota provides a protecting shield from invasion by pathogens in the wild, outcompeting their growth in specific ecological niches. We applied ultrahigh-throughput microfluidic technologies for functional profiling of microbiomes of wild animals, including the skin beetle, Siberian lynx, common raccoon dog, and East Siberian brown bear. Single-cell screening of the most efficient killers of the common human pathogen <italic toggle="yes">Staphylococcus aureus</italic> resulted in repeated isolation of <italic toggle="yes">Bacillus pumilus</italic> strains. While isolated strains had different phenotypes, all of them displayed a similar set of biosynthetic gene clusters (BGCs) encoding antibiotic amicoumacin, siderophore bacillibactin, and putative analogs of antimicrobials including bacilysin, surfactin, desferrioxamine, and class IId cyclical bacteriocin. Amicoumacin A (Ami) was identified as a major antibacterial metabolite of these strains mediating their antagonistic activity. Genome mining indicates that Ami BGCs with this architecture subdivide into three distinct families, characteristic of the <italic toggle="yes">B. pumilus</italic>, <italic toggle="yes">B. subtilis</italic>, and <italic toggle="yes">Paenibacillus</italic> species. While Ami itself displays mediocre activity against the majority of Gram-negative bacteria, isolated <italic toggle="yes">B. pumilus</italic> strains efficiently inhibit the growth of both Gram-positive <italic toggle="yes">S. aureus</italic> and Gram-negative <italic toggle="yes">E. coli</italic> in coculture. We believe that the expanded antagonistic activity spectrum of Ami-producing <italic toggle="yes">B. pumilus</italic> can be attributed to the metabolomic profile predetermined by their biosynthetic fingerprint. Ultrahigh-throughput isolation of natural probiotic strains from wild animal microbiomes, as well as their metabolic reprogramming, opens up a new avenue for pathogen control and microbiome remodeling in the food industry, agriculture, and healthcare.</p></abstract><kwd-group><kwd>ultrahigh-throughput screening</kwd><kwd>biodiversity</kwd><kwd>wild animal microbiomes</kwd><kwd>probiotic discovery</kwd><kwd>droplet microfluidics</kwd><kwd>amicoumacin</kwd><kwd>biosynthetic gene clusters (BGCs)</kwd><kwd>metabolomic fingerprinting</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-ijms-23-01168"><title>1. Introduction</title><p>The biodiversity of microbial communities is maintained by the counteraction of the production and degradation of antibiotics [<xref rid="B1-ijms-23-01168" ref-type="bibr">1</xref>]. The external influence of disinfectants and antibiotics drives additional selective pressures, dramatically reducing the biodiversity of microbiomes [<xref rid="B2-ijms-23-01168" ref-type="bibr">2</xref>,<xref rid="B3-ijms-23-01168" ref-type="bibr">3</xref>] and providing conditions for antibiotic resistance propagation [<xref rid="B4-ijms-23-01168" ref-type="bibr">4</xref>] and evolution [<xref rid="B5-ijms-23-01168" ref-type="bibr">5</xref>]. Reduced microbiome biodiversity, in turn, is attributed to its impaired functionality [<xref rid="B6-ijms-23-01168" ref-type="bibr">6</xref>,<xref rid="B7-ijms-23-01168" ref-type="bibr">7</xref>] and health disorders [<xref rid="B8-ijms-23-01168" ref-type="bibr">8</xref>], including the emergence and transmission of infectious diseases [<xref rid="B9-ijms-23-01168" ref-type="bibr">9</xref>], autoimmune diseases [<xref rid="B10-ijms-23-01168" ref-type="bibr">10</xref>,<xref rid="B11-ijms-23-01168" ref-type="bibr">11</xref>], and allergic diseases [<xref rid="B12-ijms-23-01168" ref-type="bibr">12</xref>,<xref rid="B13-ijms-23-01168" ref-type="bibr">13</xref>]. Hence, directed microbiome remodeling provides pronounced health benefits and creates alternative therapeutic strategies [<xref rid="B14-ijms-23-01168" ref-type="bibr">14</xref>]. Probiotics are applied to restore the composition of the microbiome and introduce beneficial functions to microbial communities [<xref rid="B15-ijms-23-01168" ref-type="bibr">15</xref>]. Commensals serve as probiotics competing with opportunistic pathogens in natural microbiomes [<xref rid="B16-ijms-23-01168" ref-type="bibr">16</xref>]. Therefore, probiotic strains may be isolated in microbiomes resistant to pathogen invasion [<xref rid="B17-ijms-23-01168" ref-type="bibr">17</xref>]. Looking for diverse na&#x000ef;ve microbiomes as sources for probiotic strains, we addressed wild animals living in natural aseptic conditions and facing a broad range of microorganisms, including pathogens and invasive species.</p><p>To explore probiotic strains in wild animal microbiomes, we applied an ultrahigh-throughput microfluidic platform for profiling of antimicrobial activity on a single-cell level [<xref rid="B18-ijms-23-01168" ref-type="bibr">18</xref>,<xref rid="B19-ijms-23-01168" ref-type="bibr">19</xref>,<xref rid="B20-ijms-23-01168" ref-type="bibr">20</xref>]. This technology enables us to select the most efficient bacterial antagonists from the whole microbiome. A critical step is a single-cell cocultivation of microbiome biodiversity together with a reporter fluorescent pathogen in emulsion droplets, followed by the selection of reporter-free droplets using fluorescence-activated cell sorting and regeneration of effector strains. The principal advantage of this platform is its unprecedented productivity, which allows us to uncover rare probiotic strains with the most pronounced pathogen killing. Previously, the highly potent <italic toggle="yes">Bacillus pumilus</italic> 124 strain producing antibiotic amicoumacin A (Ami) was identified as a component of the microbiome of the East Siberian brown bear (<italic toggle="yes">Ursus arctos collaris</italic>), which is highly active against the common human pathogen <italic toggle="yes">Staphylococcus aureus</italic> [<xref rid="B19-ijms-23-01168" ref-type="bibr">19</xref>]. Originally, Ami was isolated from the <italic toggle="yes">B. pumilus</italic> BN-103 strain [<xref rid="B21-ijms-23-01168" ref-type="bibr">21</xref>]. However, numerous <italic toggle="yes">B. subtilis</italic> selected for their antibacterial activity also mediate their antagonistic properties via Ami production, and some of them were isolated from the human microbiome [<xref rid="B22-ijms-23-01168" ref-type="bibr">22</xref>,<xref rid="B23-ijms-23-01168" ref-type="bibr">23</xref>]. Both <italic toggle="yes">B. subtilis</italic> and <italic toggle="yes">B. pumilus</italic> strains are widely used as probiotics for broiler chickens [<xref rid="B24-ijms-23-01168" ref-type="bibr">24</xref>], pigs [<xref rid="B25-ijms-23-01168" ref-type="bibr">25</xref>], aquaculture [<xref rid="B26-ijms-23-01168" ref-type="bibr">26</xref>], and human use [<xref rid="B27-ijms-23-01168" ref-type="bibr">27</xref>]. Despite their broad use, their genotypes and biosynthetic profiles are rarely characterized in detail.</p><p>The ultrahigh-throughput microfluidic platform revealed different probiotic <italic toggle="yes">B. pumilus</italic> strains from microbiomes of diverse wild animals, including the skin beetle (<italic toggle="yes">Dermestes maculatus</italic>), Siberian lynx (<italic toggle="yes">Lynx lynx wrangeli</italic>), common raccoon dog (<italic toggle="yes">Nyctereutes procyonoides</italic>), and previously reported East Siberian brown bear (<italic toggle="yes">Ursus arctos collaris</italic>). These strains were selected based on their anti-<italic toggle="yes">S. aureus</italic> activity and demonstrated prominent antagonistic properties toward different bacteria. Ami was determined as the main antibiotic component produced by the selected strains. While Ami is active primarily against Gram-positive bacteria [<xref rid="B20-ijms-23-01168" ref-type="bibr">20</xref>], antagonistic properties of isolates were also observed against some Gram-negatives. Whole-genome sequencing and genome mining enabled us to depict a biosynthetic fingerprint of isolated <italic toggle="yes">B. pumilus</italic> strains. All their genomes have a similar set of biosynthetic gene clusters (BGCs) encoding Ami, siderophore bacillibactin, and putative analogs of antimicrobials including bacilysin, surfactin, desferrioxamine, and class IId cyclical bacteriocin. We speculate that this genotype mediates the prominent antagonism observed in coculture experiments. Genome mining indicates that Ami BGCs subdivide into three distinct families characteristic of the (i) <italic toggle="yes">B. pumilus</italic> type, (ii) <italic toggle="yes">B. subtilis</italic> type, and (iii) <italic toggle="yes">Paenibacillus</italic> type. Hence, similar antagonistic properties may be observed among these species.</p><p>We believe that the detailed genomic description and analysis of BGCs provide an essential genotype-phenotype link that will further our understanding of the exact impact of probiotics on pathogens and hosts. Ultrahigh-throughput technologies facilitate the isolation of natural probiotic strains from various microbiomes. A deep understanding of their genotype is essential for the metabolic reprogramming of probiotics. Designer probiotics for pathogen control and microbiome remodeling will provide direct benefits in the food industry, agriculture, and healthcare.</p></sec><sec sec-type="results" id="sec2-ijms-23-01168"><title>2. Results</title><sec id="sec2dot1-ijms-23-01168"><title>2.1. Deep Functional Profiling of Microbiomes of Wild Animals</title><p>Previously, an ultrahigh-throughput microfluidic platform was applied to select the most active bacterial antagonists from the human microbiome [<xref rid="B18-ijms-23-01168" ref-type="bibr">18</xref>]. In this study, this technology was adopted to select bacterial antagonists from the microbiomes of different wild animals. It was assumed that living in the wild provides additional selective pressure on wild animal microbiomes, promoting them to serve as first-line gates for pathogen invasion. Since wound licking does not result in regular acute sepsis events, it was suggested that animal bacterial communities may contain probiotic bacteria protecting hosts from pathogens. Microbiomes of wild animals, including the skin beetle (<italic toggle="yes">Dermestes maculatus</italic>), Siberian lynx (<italic toggle="yes">Lynx lynx wrangeli</italic>), common raccoon dog (<italic toggle="yes">Nyctereutes procyonoides</italic>), and East Siberian brown bear (<italic toggle="yes">Ursus arctos collaris</italic>) were investigated to select the most active probiotic strains using an ultrahigh-throughput microfluidic platform (<xref rid="ijms-23-01168-f001" ref-type="fig">Figure 1</xref>).</p><p><italic toggle="yes">Staphylococcus aureus</italic> was used as a model pathogen to select bacterial killers, abolishing its growth in coculture. Single-cell cocultivation of bacteria from microbiomes of wild animals with the reporter <italic toggle="yes">S. aureus</italic> strain in microfluidic droplets was followed by isolation of <italic toggle="yes">S. aureus</italic> killers by fluorescence-activated cell sorting (FACS) of droplet microcompartments occupied by <italic toggle="yes">S. aureus</italic> antagonists. The selected bacteria were regenerated from droplets and screened for anti-<italic toggle="yes">S. aureus</italic> activity, and the most efficient bacterial antagonists were collected for further characterization by genomics and metabolomics. Repeated isolation of <italic toggle="yes">B. pumilus</italic> strains with prominent <italic toggle="yes">S. aureus</italic> antagonism was observed using this platform. <italic toggle="yes">B. pumilus</italic> represented ~0.5&#x02013;2% of the culturable component of wild animal microbiomes.</p></sec><sec id="sec2dot2-ijms-23-01168"><title>2.2. Biosynthetic Fingerprint of Isolated B. pumilus Strains</title><p>Isolated <italic toggle="yes">B. pumilus</italic> strains demonstrated different phenotypes (colony morphology and mobility) that may be associated with their different ecological microenvironments in their hosts. Whole-genome sequencing was applied to understand the biosynthetic potential of representative <italic toggle="yes">B. pumilus</italic> strains (<xref rid="ijms-23-01168-f002" ref-type="fig">Figure 2</xref>A).</p><p>Despite different phenotypes observed and specific BGCs detected, e.g., lantibiotics in <italic toggle="yes">B. pumilus</italic> P1 strain, genome mining revealed a common set of BGCs characteristic of antagonistic <italic toggle="yes">B. pumilus</italic> strains (<xref rid="ijms-23-01168-f002" ref-type="fig">Figure 2</xref>B). BGCs of the antibiotic Ami [<xref rid="B19-ijms-23-01168" ref-type="bibr">19</xref>,<xref rid="B22-ijms-23-01168" ref-type="bibr">22</xref>] and siderophore bacillibactin [<xref rid="B28-ijms-23-01168" ref-type="bibr">28</xref>] were detected in their genomes. Moreover, a number of BGCs encoding putative analogs of antimicrobials, including bacilysin [<xref rid="B29-ijms-23-01168" ref-type="bibr">29</xref>], class IId cyclical bacteriocin, surfactin [<xref rid="B30-ijms-23-01168" ref-type="bibr">30</xref>], and desferrioxamine, were detected.</p></sec><sec id="sec2dot3-ijms-23-01168"><title>2.3. Antagonistic Properties of B. pumilus Strains</title><p>An agar overlay assay was performed to estimate the activity spectrum of selected probiotic strains (<xref rid="ijms-23-01168-f003" ref-type="fig">Figure 3</xref>). <italic toggle="yes">B. subtilis</italic> 168 was used as a negative control since it has impaired secondary metabolite biosynthesis resulting from inactive 4-phosphopantetheinyl transferase [<xref rid="B31-ijms-23-01168" ref-type="bibr">31</xref>].</p><p>All the selected strains efficiently inhibited the growth of Gram-positive non-spore-forming bacteria, displaying mediocre activity against Gram-negative strains (<xref rid="ijms-23-01168-f003" ref-type="fig">Figure 3</xref>A,B). Large clearance zones were observed for various <italic toggle="yes">Staphylococcus</italic> species (<italic toggle="yes">S. aureus</italic>, <italic toggle="yes">S. epidermidis,</italic> and <italic toggle="yes">S. haemolyticus</italic>), <italic toggle="yes">Lactococcus lactis</italic>, <italic toggle="yes">Macrococcus caseolyticus</italic>, <italic toggle="yes">Micrococcus luteus</italic>, <italic toggle="yes">Aerococcus viridans</italic>, and <italic toggle="yes">Escherichia coli &#x00394;tolC</italic>. A less pronounced inhibitory effect was detected for <italic toggle="yes">Enterococcus faecium</italic>, <italic toggle="yes">E. coli</italic> BL21, and <italic toggle="yes">Citrobacter koseri</italic>. Small diffusive zones of growth inhibition were observed for <italic toggle="yes">Pseudomonas aeruginosa</italic> and <italic toggle="yes">Enterobacter cloacae</italic>. No clearance zones were detected for <italic toggle="yes">Acinetobacter baumanii</italic>, <italic toggle="yes">Klebsiella pneumoniae</italic>, <italic toggle="yes">Morganella morganii</italic>, <italic toggle="yes">Salmonella enterica</italic>, and <italic toggle="yes">Serratia marcenscens</italic>. <italic toggle="yes">B. pumilus</italic> D10 demonstrated the most prominent antagonistic activity on agar plates (<xref rid="ijms-23-01168-f003" ref-type="fig">Figure 3</xref>A,B).</p><p>The antagonistic properties of <italic toggle="yes">B. pumilus</italic> strains generally correlated with the Ami activity spectrum reported previously [<xref rid="B20-ijms-23-01168" ref-type="bibr">20</xref>]. Activity-based metabolomic analysis revealed that Ami was the only antibiotic component mediating the bactericidal effect against <italic toggle="yes">S. aureus</italic> in culture media of <italic toggle="yes">B. pumilus</italic> D10, P1, E14, and 124. Amicoumacin B (AmiB) and amicoumacin C (AmiC) resulting from Ami lactonization (AmiC) followed by hydrolysis (AmiB) were also detected as inactive metabolites of Ami (<xref rid="app1-ijms-23-01168" ref-type="app">Figures S1&#x02013;S4</xref>). The selected strains were compared based on their level of Ami production (<xref rid="ijms-23-01168-f003" ref-type="fig">Figure 3</xref>C). <italic toggle="yes">B. pumilus</italic> strains showed maximum Ami production after 60 h of cultivation. <italic toggle="yes">B. pumilus</italic> D10 produced the highest concentrations of Ami.</p><p>Cocultivation of the probiotic <italic toggle="yes">B. pumilus</italic> D10 strain with model reporter pathogens <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">E. coli</italic> was provided using different target: effector ratios to detail its antagonistic landscape (<xref rid="ijms-23-01168-f004" ref-type="fig">Figure 4</xref> and <xref rid="app1-ijms-23-01168" ref-type="app">Figure S5</xref>). Reporter strains producing fluorescent proteins enabled time-resolved detecting of growth inhibition.</p><p>A fluorescence level above 20% of the maximal was observed for the control <italic toggle="yes">B. subtilis</italic> 168 even at low target: effector ratios (<xref rid="ijms-23-01168-f004" ref-type="fig">Figure 4</xref>A,C). Similar effects were observed for coculturing of <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">E. coli</italic> cells (<xref rid="app1-ijms-23-01168" ref-type="app">Figure S5</xref>). We associate this effect with the competition of microorganisms for nutrients. Unlike <italic toggle="yes">B. subtilis</italic> 168, <italic toggle="yes">B. pumilus</italic> D10 efficiently inhibited the growth of reporter bacteria (<xref rid="ijms-23-01168-f004" ref-type="fig">Figure 4</xref>B,D). The effect of cocultivation on the target bacteria was more complex than the effect of pure Ami. While it is impossible to eradicate <italic toggle="yes">E. coli</italic> cells using Ami alone, as little as 10<sup>4</sup> CFU/mL <italic toggle="yes">B. pumilus</italic> D10 provided detectable eradication of both <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">E. coli</italic> within the first 24 h. The outstanding efficacy of the probiotic <italic toggle="yes">B. pumilus</italic> in coculture is essential for their ecology. Apparently, it is associated with the additional biosynthetic arsenal reported previously. We suggest that the additional secondary metabolites either potentiate Ami or increase the permeability of target cells toward Ami.</p></sec><sec id="sec2dot4-ijms-23-01168"><title>2.4. Biodiversity of Ami Clusters</title><p>The results obtained indicate a high impact of Ami-producing strains on bacterial communities. Genome mining of Ami clusters provided a detailed description of their natural landscape (<xref rid="ijms-23-01168-f005" ref-type="fig">Figure 5</xref>).</p><p>Generally, Ami clusters were identified in numerous <italic toggle="yes">Bacilli</italic> and could be subdivided into three main families characteristic of (i) <italic toggle="yes">B. pumilus</italic> type (<italic toggle="yes">B. pumilus, B. altitudinis, B. safensis, B. stratosphericus, B. zhangzhouensis, Priestia endophytica)</italic>, (ii) <italic toggle="yes">B. subtilis</italic> type (<italic toggle="yes">B. subtilis, B. bingmayongensis, B. rugosus, B. atrophaeus, B. inaquosorum, B. vallismortis</italic>, <italic toggle="yes">B. swezeyi</italic>), and (iii) <italic toggle="yes">Paenibacillus</italic> type (<italic toggle="yes">P. dendritiformis, P. solani, P. lautus, P. apiaries, P. thiaminolyticus, P. bouchesdurhonensis, P. lentus</italic>) (<xref rid="ijms-23-01168-f005" ref-type="fig">Figure 5</xref>A and <xref rid="app1-ijms-23-01168" ref-type="app">Figure S6</xref>). An Ami cluster was also identified in the rare genome of <italic toggle="yes">Paludifilum halophilum</italic>, indicating that Ami production may be observed for some <italic toggle="yes">Thermoactinomycetaceae</italic>. A closely related BGC of antibiotic zwittermicin A (ZmA) was frequently identified in <italic toggle="yes">B. cereus</italic> and <italic toggle="yes">B. thuringiensis</italic> genomes. The key hybrid PKS/NRPS enzyme AmiI encoded the structural fragment that differed between Ami and ZmA (<xref rid="ijms-23-01168-f005" ref-type="fig">Figure 5</xref>D). That enabled distinguishing between Ami clusters and related ZmA clusters (<xref rid="ijms-23-01168-f005" ref-type="fig">Figure 5</xref>B,C). ZmaK is an AmiI homolog in the ZmA cluster with a protein identity &#x0003c; 40%. Identical chemical structures were previously reported for <italic toggle="yes">B. pumilus</italic> and <italic toggle="yes">B. subtilis</italic>-type clusters, despite them having a protein identity of about 60% [<xref rid="B19-ijms-23-01168" ref-type="bibr">19</xref>,<xref rid="B22-ijms-23-01168" ref-type="bibr">22</xref>]. Hence, we propose a similar structure for products of <italic toggle="yes">Paenibacillus</italic>-type Ami-like BGCs with a synonymous modular organization (<xref rid="ijms-23-01168-f005" ref-type="fig">Figure 5</xref>C).</p><p>Ami transport and self-resistance mechanisms differ between <italic toggle="yes">Bacillus</italic> and <italic toggle="yes">Paenibacillus</italic>. Kinase AmiN and phosphatase AmiO are located downstream of the Ami cluster core, mediating Ami inactivation and reactivation, respectively [<xref rid="B19-ijms-23-01168" ref-type="bibr">19</xref>,<xref rid="B32-ijms-23-01168" ref-type="bibr">32</xref>]. Kinase AmiN is conservative in <italic toggle="yes">B. pumilus</italic>, <italic toggle="yes">B. subtilis</italic>, and <italic toggle="yes">Paludifilum</italic>-type clusters going in the same orientation as core Ami cluster genes (<xref rid="app1-ijms-23-01168" ref-type="app">Figure S6</xref>). Phosphatase AmiO is not essential for Ami clusters in <italic toggle="yes">Priestia endophytica</italic> and <italic toggle="yes">Paludifilum halophilum</italic>, indicating that alternative phosphatases in genomes of these bacteria are involved in Ami dephosphorylation. AmiO has the opposite orientation in the majority of <italic toggle="yes">B. pumilus</italic> and <italic toggle="yes">B. subtilis</italic>-type clusters, while direct orientation and transposon flanking were observed in a minor population of distant clusters (<xref rid="app1-ijms-23-01168" ref-type="app">Figure S2</xref>). That may indicate the evolution of cluster regulation and compactization. Homologs of kinase AmiN and phosphatase AmiO were not detected in <italic toggle="yes">Paenibacillus</italic>-type Ami-like BGCs. Instead, putative methyltransferase and acetyltransferase were detected downstream of the core Ami cluster genes (<xref rid="ijms-23-01168-f005" ref-type="fig">Figure 5</xref>C and <xref rid="app1-ijms-23-01168" ref-type="app">Figure S6</xref>). We suggest their involvement in self-resistance since it was reported that acetyltransferases mediate self-resistance in Ami-producing <italic toggle="yes">Xenorhabdus bovienii</italic> [<xref rid="B33-ijms-23-01168" ref-type="bibr">33</xref>] and a related ZmA cluster [<xref rid="B34-ijms-23-01168" ref-type="bibr">34</xref>]. Similarly, a transporter AmiP located upstream of core genes of the Ami cluster was not detected in <italic toggle="yes">Paenibacillus</italic>-type Ami-like BGCs (<xref rid="ijms-23-01168-f005" ref-type="fig">Figure 5</xref>C and <xref rid="app1-ijms-23-01168" ref-type="app">Figure S6</xref>). Instead, a putative C39 peptidase-containing protein was conservatively found upstream of the Ami cluster core in <italic toggle="yes">Paenibacillus</italic>-type Ami-like BGCs. We propose its involvement in transport/deacetylation in <italic toggle="yes">Paenibacillus</italic>-type BGCs.</p></sec></sec><sec sec-type="discussion" id="sec3-ijms-23-01168"><title>3. Discussion</title><p>Antibiotic misuse is particularly dangerous, and not only because it provides selective pressure for the evolution of antibiotic resistance (AR). Even more importantly, antibiotics clear the natural protective shield provided by commensals, thus outcompeting pathogens in their microenvironments. The development of probiotic strains is important in this context since they may act in a dual mode: (i) direct killing AR pathogens, and (ii) reconstituting the degraded microbiota shield. Moreover, probiotics may provide essential signals for the host immunity, regulating autoimmunity and providing stimuli often found in nature but lost during urbanization.</p><p>Here, ultrahigh-throughput microfluidic technology was applied for the isolation of bacterial killers serving as natural probiotics in the microbiomes of different wild animals. Despite the large differences in microbiota composition and the presence of source-specific killing strains, antagonistic strains of <italic toggle="yes">B. pumilus</italic> were isolated repeatedly. While a more extensive study should reveal the prevalence of the described <italic toggle="yes">B. pumilus</italic> strains in wild animals and depict their impact on hosts, the repeated isolation of antagonistic <italic toggle="yes">B. pumilus</italic> strains indicates their ubiquity and significant influence on ecological niches. Metabolomics and genomics were applied to provide a comprehensive description of these strains. Surprisingly, a common set of BGCs encoding Ami, siderophore bacillibactin, and putative analogs of antimicrobials including bacilysin, class IId cyclical bacteriocin, surfactin, and desferrioxamine was detected. Activity-based metabolomic analysis revealed that Ami is the principal antibiotic component produced by <italic toggle="yes">B. pumilus</italic>. Ami is a potent inhibitor of translation [<xref rid="B35-ijms-23-01168" ref-type="bibr">35</xref>] displaying mediocre activity against the majority of Gram-negative bacteria [<xref rid="B20-ijms-23-01168" ref-type="bibr">20</xref>]. Isolated <italic toggle="yes">B. pumilus</italic> strains efficiently inhibited the growth of both Gram-positive <italic toggle="yes">S. aureus</italic> and Gram-negative <italic toggle="yes">E. coli</italic> in coculture. We suggest that probiotic <italic toggle="yes">B. pumilus</italic> strains display their antagonistic properties by the complex action of <italic toggle="yes">B. pumilus</italic> secondary metabolites. While the exact metabolite(s), potentiating Ami are still to be determined, we believe that the discovered biosynthetic fingerprint is essential for the described antagonism.</p><p>Genome mining indicates that Ami-producing strains may be observed in numerous <italic toggle="yes">Bacillus</italic>, <italic toggle="yes">Paenibacillus</italic>, and related species. The core Ami cluster genes have similar architectures for <italic toggle="yes">Bacillus</italic> and <italic toggle="yes">Paenibacillus.</italic> However, mechanisms of Ami transport and self-resistance discovered for Ami [<xref rid="B19-ijms-23-01168" ref-type="bibr">19</xref>,<xref rid="B32-ijms-23-01168" ref-type="bibr">32</xref>] are different in <italic toggle="yes">Paenibacillus</italic>. We speculate that Ami acetylation may take place, as was previously described in Ami-producing <italic toggle="yes">Xenorhabdus bovienii</italic> [<xref rid="B33-ijms-23-01168" ref-type="bibr">33</xref>] and a related ZmA cluster [<xref rid="B34-ijms-23-01168" ref-type="bibr">34</xref>]. The fact that Ami BGCs were identified both in Gram-negative <italic toggle="yes">X. bovienii</italic> [<xref rid="B33-ijms-23-01168" ref-type="bibr">33</xref>] and Gram-positive <italic toggle="yes">Bacillus</italic> [<xref rid="B19-ijms-23-01168" ref-type="bibr">19</xref>,<xref rid="B22-ijms-23-01168" ref-type="bibr">22</xref>] is particularly interesting. These clusters have different architectures and operate different self-resistance mechanisms. However, they encode the same low-molecular metabolite, representing an outstanding example of the convergent evolution of BGCs. The described probiotic activity of isolated <italic toggle="yes">B. pumilus</italic> strains together with the interspecial diversity of Ami clusters imply a high impact of Ami-producing strains on bacterial communities.</p><p>The development of functional probiotics demands thorough characterization of their genotype and metabolomic profile. <italic toggle="yes">Bacillus</italic> species are common commercial probiotic products. However, particular probiotic strains may carry a latent threat in their genomes. That was reported for some <italic toggle="yes">B. cereus</italic> strains producing enterotoxins, which makes them unsafe for human use [<xref rid="B27-ijms-23-01168" ref-type="bibr">27</xref>]. While homologs of Hbl and Nhe enterotoxins were not identified in the selected probiotic <italic toggle="yes">B. pumilus</italic> strains, their safety and impact on microbiomes are still to be determined precisely. The creation of designer probiotics with deleted toxins and transferred BGCs encoding microbiome reprogramming metabolites represents a new paradigm of probiotic development. We believe that ultrahigh-throughput isolation of natural probiotic strains from wildlife microbiomes, as well as their metabolic reprogramming, opens up a new avenue for pathogen control and microbiome remodeling in the food industry, agriculture, and healthcare.</p></sec><sec sec-type="conclusions" id="sec4-ijms-23-01168"><title>4. Conclusions</title><p>Ultrahigh-throughput microfluidic technology was applied for the isolation of bacterial killers serving as natural probiotics in the microbiomes of different wild animals. Despite the large differences in microbiota composition and the presence of source-specific killing strains, antagonistic strains of <italic toggle="yes">B. pumilus</italic> were isolated repeatedly. Metabolomics and genomics were applied to provide a comprehensive description of these strains. A common biosynthetic fingerprint was detected. Activity-based metabolomic analysis revealed that Ami is the principal antibiotic component produced by <italic toggle="yes">B. pumilus</italic>. While Ami itself displays mediocre activity against Gram-negative bacteria, isolated <italic toggle="yes">B. pumilus</italic> strains efficiently inhibit the growth of both Gram-positive <italic toggle="yes">S. aureus</italic> and Gram-negative <italic toggle="yes">E. coli</italic> in coculture. We believe that the expanded antagonistic activity spectrum of Ami-producing <italic toggle="yes">B. pumilus</italic> can be attributed to the metabolomic profile predetermined by their biosynthetic fingerprint. Ultrahigh-throughput isolation of natural probiotic strains from wild animal microbiomes, as well as their metabolic reprogramming, opens up a new avenue for pathogen control and microbiome remodeling in the food industry, agriculture, and healthcare.</p></sec><sec id="sec5-ijms-23-01168"><title>5. Materials and Methods</title><p><bold>Bacterial strains.</bold> A bacterial collection of clinical isolates including <italic toggle="yes">Acinetobacter baumannii, Aerococcus viridans, Citrobacter koseri, Enterobacter cloacae, Enterococcus faecium, Klebsiella pneumoniae, Lactococcus lactis, Macrococcus caseolyticus, Micrococcus luteus, Morganella morganii, Pseudomonas aeruginosa, Salmonella enterica, Staphylococcus epidermidis</italic>, and <italic toggle="yes">Staphylococcus haemolyticus</italic> was kindly provided by Lytech Co. Ltd. (Moscow, Russia). GFP-producing <italic toggle="yes">Staphylococcus aureus</italic> was described previously [<xref rid="B18-ijms-23-01168" ref-type="bibr">18</xref>]. <italic toggle="yes">Escherichia coli</italic> BW25113 &#x00394;tolC was kindly provided by Ilya A. Osterman, Moscow State University. The <italic toggle="yes">Bacillus subtilis</italic> 168 ATCC 23857 <italic toggle="yes">E. coli</italic> BL21 (DE3) strain (Invitrogen, Waltham, MA, USA) was transformed with a pKatushka2S-B vector (Evrogen, Moscow, Russia) to provide far-red fluorescent reporter <italic toggle="yes">E. coli</italic> cells.</p><p><bold>Microbiota collection.</bold> Oral microbiota samples were collected from healthy a Siberian lynx (<italic toggle="yes">Lynx lynx wrangeli</italic>) and common raccoon dog (<italic toggle="yes">Nyctereutes procyonoides</italic>) using a noninvasive probe immediately after capture in Primorsky Krai, Russia. The noninvasive probe containing the collected microbiota samples was thoroughly washed with a sterile medium for microbiota cryopreservation. The cell suspension was immediately frozen in liquid nitrogen, transported in dry ice, and stored in liquid nitrogen. The oral microbiota of an East Siberian brown bear (<italic toggle="yes">Ursus arctos collaris</italic>) was collected previously [<xref rid="B19-ijms-23-01168" ref-type="bibr">19</xref>] and stored in liquid nitrogen. Skin beetle (<italic toggle="yes">Dermestes maculatus</italic>) imago were extensively washed with a sterile PBS buffer and homogenized using a manual French press. The residual was thoroughly washed with a sterile medium, frozen, and stored in liquid nitrogen.</p><p><bold>Deep functional profiling.</bold> The application of ultrahigh-throughput microfluidic technology for the selection of bacteria displaying anti-<italic toggle="yes">S. aureus</italic> activity was described in detail previously [<xref rid="B18-ijms-23-01168" ref-type="bibr">18</xref>,<xref rid="B19-ijms-23-01168" ref-type="bibr">19</xref>]. Target <italic toggle="yes">S. aureus</italic> cells producing a GFP reporter were vitally stained with sulfo-Cyanine5 NHS (Lumiprobe, Moscow, Russia), washed, filtered using 20 &#x003bc;m solvent filters (A-313, IDEX, Northbrook, IL, USA), and coencapsulated with a microbiota suspension in droplets of microfluidic double emulsion (MDE), using 20 &#x003bc;m microfluidic chips produced via soft lithography. The microbiota samples were unfrozen directly before encapsulation, resuspended in a BHI broth (BD, Franklin Lakes, NJ, USA), and filtered through 40 &#x003bc;m cell strainers (Greiner Bio-One, Kremsm&#x000fc;nster, Austria). After overnight incubation at 30&#x02013;35 &#x000b0;C, Calcein Violet AM (Thermo Fisher Scientific, Waltham, MA, USA) was added to the droplet emulsion to the final concentration of 10 &#x003bc;M. Subsequently, the droplets with simultaneous sCy5<sup>high</sup>, GFP<sup>low</sup>, and Calcein Violet<sup>high</sup> fluorescence were sorted using a FACSAria III cell sorter (BD, USA). Bacterial colonies were regenerated after plating on BHI&#x02013;agar (BD, Franklin Lakes, NJ, USA) and tested for anti-<italic toggle="yes">S. aureus</italic> activity using the agar overlay assay. Bacterial clones demonstrating <italic toggle="yes">S. aureus</italic> antagonism were identified by mass spectrometry and studied by metabolomic analysis and whole-genome sequencing.</p><p><bold>Identification of bacteria using mass spectrometry.</bold> Bacterial cells were spotted on a sample spot of a MALDI target plate (MSP 96 target, ground steel; Bruker Daltonics, Billerica, MA, USA) and were overlaid with HCCA matrix solution (saturated solution of &#x003b1;-4-cyano-hydroxycinnamic acid; Bruker Daltonics, Billerica, MA, USA) in 50% acetonitrile (Sigma-Aldrich, St. Louis, MO, USA) and 2.5% trifluoroacetic acid solution (Sigma-Aldrich, St. Louis, MO, USA). Mass spectra profiles were acquired using a Microflex spectrometer (Bruker Daltonics, Billerica, MA, USA). The molecular ions were measured automatically in the linear positive ion mode with the instrument parameters optimized for a range of 2000&#x02013;20,000 <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic>. The software packages flexControl 3.0 (Bruker Daltonics, Billerica, MA, USA) and flexAnalysis 3.0 (Bruker Daltonics, Billerica, MA, USA) were used for mass spectra recording and processing. Spectra identification and analysis were carried out using the MALDI Biotyper 3.0 (Bruker Daltonics, Billerica, MA, USA). The identification was performed by comparing the obtained spectra with those in the MALDI Biotyper 3.0 library (version 3.2.1.1).</p><p><bold>Whole-genome sequencing and bioinformatic analysis.</bold> Pure genomic DNA (approx. 500&#x02009;ng) was fragmented to a mean size of 200&#x02013;300 bp using the Covaris S220 System (Covaris, Woburn, MA, USA). A KAPA Library Preparation Kit (KAPA Biosystems, Wilmington, MA, USA) was employed to prepare a barcoded shotgun library. Emulsion PCR was performed using a One Touch system (ThermoFisher Scientific, Waltham, MA, USA). Beads were prepared using the One Touch 2 and Template Kit v2, and sequencing was performed using an Ion Proton 200 Sequencing Kit v2 and P1 Ion chip. De novo assembly was performed by SPAdes 3.14.0 [<xref rid="B36-ijms-23-01168" ref-type="bibr">36</xref>] using default parameters. Identification of the protein-coding sequences and primary annotation were performed using PROKKA v1.14.6 [<xref rid="B37-ijms-23-01168" ref-type="bibr">37</xref>]. Identification of biosynthetic gene clusters and NRPS modular organization was performed with antiSMASH 6.0 [<xref rid="B38-ijms-23-01168" ref-type="bibr">38</xref>]. Comparative analysis of homologous gene clusters was provided by MultiGeneBlast [<xref rid="B39-ijms-23-01168" ref-type="bibr">39</xref>].</p><p><bold>Agar overlay assay.</bold> Antagonistic <italic toggle="yes">Bacillus</italic> strains were grown overnight in liquid cultures at 30 &#x000b0;C. Taken from those cultures, 2 &#x000b5;L aliquots were plated on 2YT (BD, Franklin Lakes, NJ, USA) agar plates to form regular colonies. The colonies were cultivated at 30 &#x000b0;C followed by chloroform vapor treatment for 5 min. The agar overlay assay was performed using soft agar (8 g/L tryptone, 5 g/L yeast extract, 2.5 g/L NaCl, 0.5% agar). Soft agar was melted, cooled to 40 &#x000b0;C, and inoculated with an overnight culture of the target microorganism using a 1:1000 dilution. Next, 7 mL of resulting liquid soft agar was used to overlay <italic toggle="yes">Bacillus</italic> colonies. Agar plates were incubated overnight at 30 &#x000b0;C after soft-agar solidification. Clearance zones were measured in three biological replicates.</p><p><bold>Metabolomic analysis.</bold>&#x000a0;<italic toggle="yes">B. pumilus</italic> D10, P1, E14, and 124 culture media collected after 60 h of cultivation were used to determine the major active compound for each strain. Cells were pelleted at 10,000&#x000d7; <italic toggle="yes">g</italic>, the supernatant was filtered using a Millistak + HC Pod Depth Filter (Millipore, Billerica, MA, USA), and then it was fractionated with a Symmetry C18 (Waters) RP-HPLC column using buffer A (20 mM NH<sub>4</sub>OAc pH 5.0, 5% ACN) and B (20 mM NH<sub>4</sub>OAc pH 5.0, 80% ACN), with a flow rate of 1 mL/min and 40-min linear gradient. Then, 1-min fractions were collected and analyzed for antibiotic activity using reporter <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">E. coli</italic> cells. Antibiotic activity was detected only in fractions corresponding to Ami. LC-MS analysis was carried out on an Ultimate 3000 RSLCnano HPLC system connected to an Orbitrap Fusion Lumos mass spectrometer (ThermoFisher Scientific, Waltham, MA, USA), with the loading pump used for analytical flow-gradient delivery. Samples were separated on a Luna Omega C18 1.6 &#x000b5;m 100 &#x000c5; column 100 &#x000d7; 2.1 mm at a 200 &#x000b5;L/min flow rate. Separation was done by a gradient of 99.9% ACN, 10 mM ammonium formate, and 0.1% FA (Buffer B), or 99.9% H<sub>2</sub>O, 10 mM ammonium formate, and 0.1% FA (Buffer A): 5% B at 0 min, 5% B at 5 min, and 99% B at 20 min, followed by a 5 min wash at 99% B and 10 min equilibration at 5% B before the next run. UV data were collected at 260 and 315 nm. MS1 spectra were collected in the positive ion mode at a 30 K Orbitrap resolution and in the profile mode with a 200&#x02013;2000 a.e.m mass range and RF lens 30%. For the rest of the MS1 parameters, as well as for the ESI parameters, the default values suggested by Xcalibur software ver. 4.3.73.11 (ThermoFisher Scientific, Waltham, MA, USA) were taken. MS2 precursors were selected based on the MS1 intensity: the intensity threshold was 5 &#x000d7; 104 with the dynamic exclusion set to 10 s after two selections, with the mass tolerance of 10 ppm and isotope exclusion. MS2 spectra were collected at 15-K resolution in the centroid mode. The isolation window was set to 1/6 <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> with no offset and the quadrupole isolation mode. Fragmentation was done by HCD with a stepped CE of 20, 35, and 50%. The rest of the MS2 parameters were taken as default values. The total MS1-MS2 cycle time was set to 1 s. Ami and its metabolites were identified with molecular masses and their fragmentation spectra were as described previously [<xref rid="B19-ijms-23-01168" ref-type="bibr">19</xref>].</p><p><bold>Antibiotic activity testing.</bold> Inhibition of bacterial cell growth was measured by a doubling dilution of culture media and C18 HPLC fractions in a 2YT medium supplemented with 20 &#x000b5;g/mL chloramphenicol inoculated with <italic toggle="yes">E. coli</italic> or <italic toggle="yes">S. aureus</italic> to OD<sub>600</sub> ~0.001. After overnight incubation at 30 &#x000b0;C, bacterial growth was analyzed by GFP fluorescence (&#x003bb;<sub>ex</sub>/&#x003bb;<sub>em</sub> = 488/513 nm) and OD<sub>600</sub> using a Varioskan Flash Multimode Reader (ThermoFisher Scientific, Waltham, MA, USA).</p><p><bold>Quantification of Ami production.</bold><italic toggle="yes">B. pumilus</italic> strains were cultivated in SYC medium (40 g/L sucrose, 5 g/L yeast extract, 4 g/L CaCO<sub>3</sub>, 1.5 g/L K<sub>2</sub>HPO<sub>4</sub>, 2 g/L glucose, 2 g/L NaCl, 1.5 g/L MgSO<sub>4</sub>, 2 g/L (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub>, 0.01 g/L FeSO<sub>4</sub>, 0.01 g/L MnCl<sub>2</sub>) at 30 &#x000b0;C. <italic toggle="yes">B. pumilus</italic> strains were inoculated from an overnight culture (using 1:100 dilution) and cultivated using 750-mL flasks in 100 mL with 220 rpm shaking. Culture media were analyzed by RP-HPLC as was previously described. Amicoumacin and its derivatives were monitored by absorbance at 315 nm. The concentration of Ami was measured using the purified Ami standard, <inline-formula><mml:math id="mm1" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mi mathvariant="sans-serif">&#x003b5;</mml:mi><mml:mrow><mml:mn>315</mml:mn><mml:mrow><mml:mo>&#x000a0;</mml:mo><mml:mi>nm</mml:mi></mml:mrow></mml:mrow><mml:mrow><mml:mi>MeOH</mml:mi></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mn>4380</mml:mn><mml:mo>&#x000a0;</mml:mo><mml:msup><mml:mi mathvariant="normal">M</mml:mi><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:msup><mml:mrow><mml:mi>cm</mml:mi></mml:mrow><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula>.</p><p><bold>Growth inhibition landscapes.</bold> The inhibitory landscapes were obtained by cocultivation of reporter cells with antagonistic <italic toggle="yes">B. pumilus</italic> strains using various cell ratios. Target reporter bacteria <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">E. coli</italic> produced intracellular GFP and Katushka2S fluorescent proteins, respectively. <italic toggle="yes">B. subtilis</italic> 168 was used as a negative control. Concentrations of target and effector bacteria were varied in the 10<sup>3</sup>&#x02013;10<sup>8</sup> CFU/mL range and 10<sup>4</sup>&#x02013;10<sup>8</sup> CFU/mL range, respectively. Serial three-fold dilutions in a 2YT medium were used. Cocultures were cultivated in 96-well plates using a microplate shaker at 35 &#x000b0;C and 600 rpm for 24 h. The target bacteria growth was monitored by GFP and Katushka2S fluorescence using a Varioskan Flash multimode reader (Thermo Fisher Scientific, Waltham, MA, USA).</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><app-group><app id="app1-ijms-23-01168"><title>Supplementary Materials</title><p>The following are available online at <uri xlink:href="https://www.mdpi.com/article/10.3390/ijms23031168/s1">https://www.mdpi.com/article/10.3390/ijms23031168/s1</uri>.</p><supplementary-material id="ijms-23-01168-s001" position="float" content-type="local-data"><media xlink:href="ijms-23-01168-s001.zip"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Y.N.Z., E.N.I., A.G.G., I.V.S. and S.S.T. designed the research; M.N.B., A.M.K., Y.A.M., V.V.B., M.A.K., M.V.M., V.G.Y. and I.V.S. performed the research; M.P.R., A.Z., O.A.B. and S.K. contributed new analytic tools; M.N.B., Y.N.Z., E.N.I., A.G.G., I.V.S. and S.S.T. analyzed the data; M.N.B., A.G.G., I.V.S. and S.S.T. wrote the paper. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This work was supported by a grant from the Ministry of Science and Higher Education of the Russian Federation No. 075-15-2021-1049.</p></notes><notes><title>Institutional Review Board Statement</title><p>The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board of the Federal Scientific Center of the East Asia Terrestrial Biodiversity (protocol code 027/3, approved 11 March 2020).</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The whole genome sequencing data of <italic toggle="yes">B. pumilus</italic> strain 124 from the East Siberian brown bear is available in the GenBank database, <uri xlink:href="https://www.ncbi.nlm.nih.gov/genbank/">https://www.ncbi.nlm.nih.gov/genbank/</uri> (accession no. QENN00000000) (accessed on 15 November 2021). A representative Ami BGC from <italic toggle="yes">B. pumilus</italic> P1 isolated from the Siberian lynx was deposited in the GenBank database, <uri xlink:href="https://www.ncbi.nlm.nih.gov/genbank/">https://www.ncbi.nlm.nih.gov/genbank/</uri> (accession no. OM289665) (accessed on 15 November 2021).</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-ijms-23-01168"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kelsic</surname><given-names>E.D.</given-names></name>
<name><surname>Zhao</surname><given-names>J.</given-names></name>
<name><surname>Vetsigian</surname><given-names>K.</given-names></name>
<name><surname>Kishony</surname><given-names>R.</given-names></name>
</person-group><article-title>Counteraction of antibiotic production and degradation stabilizes microbial communities</article-title><source>Nature</source><year>2015</year><volume>521</volume><fpage>516</fpage><lpage>519</lpage><pub-id pub-id-type="doi">10.1038/nature14485</pub-id><pub-id pub-id-type="pmid">25992546</pub-id></element-citation></ref><ref id="B2-ijms-23-01168"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Meade</surname><given-names>E.</given-names></name>
<name><surname>Slattery</surname><given-names>M.A.</given-names></name>
<name><surname>Garvey</surname><given-names>M.</given-names></name>
</person-group><article-title>Biocidal Resistance in Clinically Relevant Microbial Species: A Major Public Health Risk</article-title><source>Pathogens</source><year>2021</year><volume>10</volume><elocation-id>598</elocation-id><pub-id pub-id-type="doi">10.3390/pathogens10050598</pub-id><?supplied-pmid 34068912?><pub-id pub-id-type="pmid">34068912</pub-id></element-citation></ref><ref id="B3-ijms-23-01168"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>McDonnell</surname><given-names>G.</given-names></name>
<name><surname>Russell</surname><given-names>A.D.</given-names></name>
</person-group><article-title>Antiseptics and Disinfectants: Activity, Action, and Resistance</article-title><source>Clin. Microbiol. Rev.</source><year>1999</year><volume>12</volume><fpage>147</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1128/CMR.12.1.147</pub-id><?supplied-pmid 9880479?><pub-id pub-id-type="pmid">9880479</pub-id></element-citation></ref><ref id="B4-ijms-23-01168"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hartmann</surname><given-names>E.M.</given-names></name>
<name><surname>Hickey</surname><given-names>R.</given-names></name>
<name><surname>Hsu</surname><given-names>T.</given-names></name>
<name><surname>Betancourt Rom&#x000e1;n</surname><given-names>C.M.</given-names></name>
<name><surname>Chen</surname><given-names>J.</given-names></name>
<name><surname>Schwager</surname><given-names>R.</given-names></name>
<name><surname>Kline</surname><given-names>J.</given-names></name>
<name><surname>Brown</surname><given-names>G.Z.</given-names></name>
<name><surname>Halden</surname><given-names>R.U.</given-names></name>
<name><surname>Huttenhower</surname><given-names>C.</given-names></name>
<etal/>
</person-group><article-title>Antimicrobial Chemicals Are Associated with Elevated Antibiotic Resistance Genes in the Indoor Dust Microbiome</article-title><source>Environ. Sci. Technol.</source><year>2016</year><volume>50</volume><fpage>9807</fpage><lpage>9815</lpage><pub-id pub-id-type="doi">10.1021/acs.est.6b00262</pub-id><?supplied-pmid 27599587?><pub-id pub-id-type="pmid">27599587</pub-id></element-citation></ref><ref id="B5-ijms-23-01168"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Crofts</surname><given-names>T.S.</given-names></name>
<name><surname>Gasparrini</surname><given-names>A.J.</given-names></name>
<name><surname>Dantas</surname><given-names>G.</given-names></name>
</person-group><article-title>Next-generation approaches to understand and combat the antibiotic resistome</article-title><source>Nat. Rev. Microbiol.</source><year>2017</year><volume>15</volume><fpage>422</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.1038/nrmicro.2017.28</pub-id><?supplied-pmid 28392565?><pub-id pub-id-type="pmid">28392565</pub-id></element-citation></ref><ref id="B6-ijms-23-01168"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wagg</surname><given-names>C.</given-names></name>
<name><surname>Schlaeppi</surname><given-names>K.</given-names></name>
<name><surname>Banerjee</surname><given-names>S.</given-names></name>
<name><surname>Kuramae</surname><given-names>E.E.</given-names></name>
<name><surname>van der Heijden</surname><given-names>M.G.A.</given-names></name>
</person-group><article-title>Fungal-bacterial diversity and microbiome complexity predict ecosystem functioning</article-title><source>Nat. Commun.</source><year>2019</year><volume>10</volume><fpage>4841</fpage><pub-id pub-id-type="doi">10.1038/s41467-019-12798-y</pub-id><?supplied-pmid 31649246?><pub-id pub-id-type="pmid">31649246</pub-id></element-citation></ref><ref id="B7-ijms-23-01168"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lozupone</surname><given-names>C.A.</given-names></name>
<name><surname>Stombaugh</surname><given-names>J.I.</given-names></name>
<name><surname>Gordon</surname><given-names>J.I.</given-names></name>
<name><surname>Jansson</surname><given-names>J.K.</given-names></name>
<name><surname>Knight</surname><given-names>R.</given-names></name>
</person-group><article-title>Diversity, stability and resilience of the human gut microbiota</article-title><source>Nature</source><year>2012</year><volume>489</volume><fpage>220</fpage><lpage>230</lpage><pub-id pub-id-type="doi">10.1038/nature11550</pub-id><?supplied-pmid 22972295?><pub-id pub-id-type="pmid">22972295</pub-id></element-citation></ref><ref id="B8-ijms-23-01168"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mosca</surname><given-names>A.</given-names></name>
<name><surname>Leclerc</surname><given-names>M.</given-names></name>
<name><surname>Hugot</surname><given-names>J.P.</given-names></name>
</person-group><article-title>Gut Microbiota Diversity and Human Diseases: Should We Reintroduce Key Predators in Our Ecosystem?</article-title><source>Front. Microbiol.</source><year>2016</year><volume>7</volume><fpage>455</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2016.00455</pub-id><pub-id pub-id-type="pmid">27065999</pub-id></element-citation></ref><ref id="B9-ijms-23-01168"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Keesing</surname><given-names>F.</given-names></name>
<name><surname>Belden</surname><given-names>L.K.</given-names></name>
<name><surname>Daszak</surname><given-names>P.</given-names></name>
<name><surname>Dobson</surname><given-names>A.</given-names></name>
<name><surname>Harvell</surname><given-names>C.D.</given-names></name>
<name><surname>Holt</surname><given-names>R.D.</given-names></name>
<name><surname>Hudson</surname><given-names>P.</given-names></name>
<name><surname>Jolles</surname><given-names>A.</given-names></name>
<name><surname>Jones</surname><given-names>K.E.</given-names></name>
<name><surname>Mitchell</surname><given-names>C.E.</given-names></name>
<etal/>
</person-group><article-title>Impacts of biodiversity on the emergence and transmission of infectious diseases</article-title><source>Nature</source><year>2010</year><volume>468</volume><fpage>647</fpage><lpage>652</lpage><pub-id pub-id-type="doi">10.1038/nature09575</pub-id><?supplied-pmid 21124449?><pub-id pub-id-type="pmid">21124449</pub-id></element-citation></ref><ref id="B10-ijms-23-01168"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vatanen</surname><given-names>T.</given-names></name>
<name><surname>Kostic</surname><given-names>A.D.</given-names></name>
<name><surname>d&#x02019;Hennezel</surname><given-names>E.</given-names></name>
<name><surname>Siljander</surname><given-names>H.</given-names></name>
<name><surname>Franzosa</surname><given-names>E.A.</given-names></name>
<name><surname>Yassour</surname><given-names>M.</given-names></name>
<name><surname>Kolde</surname><given-names>R.</given-names></name>
<name><surname>Vlamakis</surname><given-names>H.</given-names></name>
<name><surname>Arthur</surname><given-names>T.D.</given-names></name>
<name><surname>H&#x000e4;m&#x000e4;l&#x000e4;inen</surname><given-names>A.-M.</given-names></name>
<etal/>
</person-group><article-title>Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans</article-title><source>Cell</source><year>2016</year><volume>165</volume><fpage>842</fpage><lpage>853</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.04.007</pub-id><pub-id pub-id-type="pmid">27133167</pub-id></element-citation></ref><ref id="B11-ijms-23-01168"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Round</surname><given-names>J.L.</given-names></name>
<name><surname>Mazmanian</surname><given-names>S.K.</given-names></name>
</person-group><article-title>Inducible Foxp3<sup>+</sup> regulatory T-cell development by a commensal bacterium of the intestinal microbiota</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2010</year><volume>107</volume><fpage>12204</fpage><lpage>12209</lpage><pub-id pub-id-type="doi">10.1073/pnas.0909122107</pub-id><pub-id pub-id-type="pmid">20566854</pub-id></element-citation></ref><ref id="B12-ijms-23-01168"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Okada</surname><given-names>H.</given-names></name>
<name><surname>Kuhn</surname><given-names>C.</given-names></name>
<name><surname>Feillet</surname><given-names>H.</given-names></name>
<name><surname>Bach</surname><given-names>J.F.</given-names></name>
</person-group><article-title>The &#x02018;hygiene hypothesis&#x02019; for autoimmune and allergic diseases: An update</article-title><source>Clin. Exp. Immunol.</source><year>2010</year><volume>160</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2249.2010.04139.x</pub-id></element-citation></ref><ref id="B13-ijms-23-01168"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hanski</surname><given-names>I.</given-names></name>
<name><surname>von Hertzen</surname><given-names>L.</given-names></name>
<name><surname>Fyhrquist</surname><given-names>N.</given-names></name>
<name><surname>Koskinen</surname><given-names>K.</given-names></name>
<name><surname>Torppa</surname><given-names>K.</given-names></name>
<name><surname>Laatikainen</surname><given-names>T.</given-names></name>
<name><surname>Karisola</surname><given-names>P.</given-names></name>
<name><surname>Auvinen</surname><given-names>P.</given-names></name>
<name><surname>Paulin</surname><given-names>L.</given-names></name>
<name><surname>M&#x000e4;kel&#x000e4;</surname><given-names>M.J.</given-names></name>
<etal/>
</person-group><article-title>Environmental biodiversity, human microbiota, and allergy are interrelated</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2012</year><volume>109</volume><fpage>8334</fpage><lpage>8339</lpage><pub-id pub-id-type="doi">10.1073/pnas.1205624109</pub-id><pub-id pub-id-type="pmid">22566627</pub-id></element-citation></ref><ref id="B14-ijms-23-01168"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>P.B.</given-names></name>
<name><surname>Black</surname><given-names>A.S.</given-names></name>
<name><surname>Sobel</surname><given-names>A.L.</given-names></name>
<name><surname>Zhao</surname><given-names>Y.</given-names></name>
<name><surname>Mukherjee</surname><given-names>P.</given-names></name>
<name><surname>Molparia</surname><given-names>B.</given-names></name>
<name><surname>Moore</surname><given-names>N.E.</given-names></name>
<name><surname>Aleman Muench</surname><given-names>G.R.</given-names></name>
<name><surname>Wu</surname><given-names>J.</given-names></name>
<name><surname>Chen</surname><given-names>W.</given-names></name>
<etal/>
</person-group><article-title>Directed remodeling of the mouse gut microbiome inhibits the development of atherosclerosis</article-title><source>Nat. Biotechnol.</source><year>2020</year><volume>38</volume><fpage>1288</fpage><lpage>1297</lpage><pub-id pub-id-type="doi">10.1038/s41587-020-0549-5</pub-id><pub-id pub-id-type="pmid">32541956</pub-id></element-citation></ref><ref id="B15-ijms-23-01168"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hemarajata</surname><given-names>P.</given-names></name>
<name><surname>Versalovic</surname><given-names>J.</given-names></name>
</person-group><article-title>Effects of probiotics on gut microbiota: Mechanisms of intestinal immunomodulation and neuromodulation</article-title><source>Ther. Adv. Gastroenterol.</source><year>2013</year><volume>6</volume><fpage>39</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1177/1756283X12459294</pub-id><?supplied-pmid 23320049?><pub-id pub-id-type="pmid">23320049</pub-id></element-citation></ref><ref id="B16-ijms-23-01168"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>O&#x02019;Toole</surname><given-names>P.W.</given-names></name>
<name><surname>Cooney</surname><given-names>J.C.</given-names></name>
</person-group><article-title>Probiotic Bacteria Influence the Composition and Function of the Intestinal Microbiota</article-title><source>Interdiscip. Perspect. Infect. Dis.</source><year>2008</year><volume>2008</volume><fpage>175285</fpage><pub-id pub-id-type="doi">10.1155/2008/175285</pub-id><?supplied-pmid 19277099?><pub-id pub-id-type="pmid">19277099</pub-id></element-citation></ref><ref id="B17-ijms-23-01168"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pickard</surname><given-names>J.M.</given-names></name>
<name><surname>Zeng</surname><given-names>M.Y.</given-names></name>
<name><surname>Caruso</surname><given-names>R.</given-names></name>
<name><surname>N&#x000fa;&#x000f1;ez</surname><given-names>G.</given-names></name>
</person-group><article-title>Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease</article-title><source>Immunol. Rev.</source><year>2017</year><volume>279</volume><fpage>70</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1111/imr.12567</pub-id><?supplied-pmid 28856738?><pub-id pub-id-type="pmid">28856738</pub-id></element-citation></ref><ref id="B18-ijms-23-01168"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Terekhov</surname><given-names>S.S.</given-names></name>
<name><surname>Smirnov</surname><given-names>I.V.</given-names></name>
<name><surname>Stepanova</surname><given-names>A.V.</given-names></name>
<name><surname>Bobik</surname><given-names>T.V.</given-names></name>
<name><surname>Mokrushina</surname><given-names>Y.A.</given-names></name>
<name><surname>Ponomarenko</surname><given-names>N.A.</given-names></name>
<name><surname>Belogurov</surname><given-names>A.A.</given-names></name>
<name><surname>Rubtsova</surname><given-names>M.P.</given-names></name>
<name><surname>Kartseva</surname><given-names>O.V.</given-names></name>
<name><surname>Gomzikova</surname><given-names>M.O.</given-names></name>
<etal/>
</person-group><article-title>Microfluidic droplet platform for ultrahigh-throughput single-cell screening of biodiversity</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2017</year><volume>114</volume><fpage>2550</fpage><lpage>2555</lpage><pub-id pub-id-type="doi">10.1073/pnas.1621226114</pub-id><?supplied-pmid 28202731?><pub-id pub-id-type="pmid">28202731</pub-id></element-citation></ref><ref id="B19-ijms-23-01168"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Terekhov</surname><given-names>S.S.</given-names></name>
<name><surname>Smirnov</surname><given-names>I.V.</given-names></name>
<name><surname>Malakhova</surname><given-names>M.V.</given-names></name>
<name><surname>Samoilov</surname><given-names>A.E.</given-names></name>
<name><surname>Manolov</surname><given-names>A.I.</given-names></name>
<name><surname>Nazarov</surname><given-names>A.S.</given-names></name>
<name><surname>Danilov</surname><given-names>D.V.</given-names></name>
<name><surname>Dubiley</surname><given-names>S.A.</given-names></name>
<name><surname>Osterman</surname><given-names>I.A.</given-names></name>
<name><surname>Rubtsova</surname><given-names>M.P.</given-names></name>
<etal/>
</person-group><article-title>Ultrahigh-throughput functional profiling of microbiota communities</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2018</year><volume>115</volume><fpage>9551</fpage><lpage>9556</lpage><pub-id pub-id-type="doi">10.1073/pnas.1811250115</pub-id><?supplied-pmid 30181282?><pub-id pub-id-type="pmid">30181282</pub-id></element-citation></ref><ref id="B20-ijms-23-01168"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Terekhov</surname><given-names>S.S.</given-names></name>
<name><surname>Nazarov</surname><given-names>A.S.</given-names></name>
<name><surname>Mokrushina</surname><given-names>Y.A.</given-names></name>
<name><surname>Baranova</surname><given-names>M.N.</given-names></name>
<name><surname>Potapova</surname><given-names>N.A.</given-names></name>
<name><surname>Malakhova</surname><given-names>M.V.</given-names></name>
<name><surname>Ilina</surname><given-names>E.N.</given-names></name>
<name><surname>Smirnov</surname><given-names>I.V.</given-names></name>
<name><surname>Gabibov</surname><given-names>A.G.</given-names></name>
</person-group><article-title>Deep Functional Profiling Facilitates the Evaluation of the Antibacterial Potential of the Antibiotic Amicoumacin</article-title><source>Antibiotics</source><year>2020</year><volume>9</volume><elocation-id>157</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics9040157</pub-id></element-citation></ref><ref id="B21-ijms-23-01168"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Itoh</surname><given-names>J.</given-names></name>
<name><surname>Omoto</surname><given-names>S.</given-names></name>
<name><surname>Nishizawa</surname><given-names>N.</given-names></name>
<name><surname>Kodama</surname><given-names>Y.</given-names></name>
<name><surname>Inouye</surname><given-names>S.</given-names></name>
</person-group><article-title>Chemical Structures of Amicoumacins Produced by <italic toggle="yes">Bacillus pumilus</italic></article-title><source>Agric. Biol. Chem.</source><year>1982</year><volume>46</volume><fpage>2659</fpage><lpage>2665</lpage><pub-id pub-id-type="doi">10.1271/bbb1961.46.2659</pub-id></element-citation></ref><ref id="B22-ijms-23-01168"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>Z.</given-names></name>
<name><surname>Yamanaka</surname><given-names>K.</given-names></name>
<name><surname>Xu</surname><given-names>Y.</given-names></name>
<name><surname>Zhang</surname><given-names>W.</given-names></name>
<name><surname>Vlamakis</surname><given-names>H.</given-names></name>
<name><surname>Kolter</surname><given-names>R.</given-names></name>
<name><surname>Moore</surname><given-names>B.S.</given-names></name>
<name><surname>Qian</surname><given-names>P.-Y.</given-names></name>
</person-group><article-title>Directed natural product biosynthesis gene cluster capture and expression in the model bacterium <italic toggle="yes">Bacillus subtilis</italic></article-title><source>Sci. Rep.</source><year>2015</year><volume>5</volume><fpage>9383</fpage><pub-id pub-id-type="doi">10.1038/srep09383</pub-id><pub-id pub-id-type="pmid">25807046</pub-id></element-citation></ref><ref id="B23-ijms-23-01168"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pinchuk</surname><given-names>I.V.</given-names></name>
<name><surname>Bressollier</surname><given-names>P.</given-names></name>
<name><surname>Sorokulova</surname><given-names>I.B.</given-names></name>
<name><surname>Verneuil</surname><given-names>B.</given-names></name>
<name><surname>Urdaci</surname><given-names>M.C.</given-names></name>
</person-group><article-title>Amicoumacin antibiotic production and genetic diversity of <italic toggle="yes">Bacillus subtilis</italic> strains isolated from different habitats</article-title><source>Res. Microbiol.</source><year>2002</year><volume>153</volume><fpage>269</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1016/S0923-2508(02)01320-7</pub-id><pub-id pub-id-type="pmid">12160317</pub-id></element-citation></ref><ref id="B24-ijms-23-01168"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bilal</surname><given-names>M.</given-names></name>
<name><surname>Si</surname><given-names>W.</given-names></name>
<name><surname>Barbe</surname><given-names>F.</given-names></name>
<name><surname>Chevaux</surname><given-names>E.</given-names></name>
<name><surname>Sienkiewicz</surname><given-names>O.</given-names></name>
<name><surname>Zhao</surname><given-names>X.</given-names></name>
</person-group><article-title>Effects of novel probiotic strains of <italic toggle="yes">Bacillus pumilus</italic> and <italic toggle="yes">Bacillus subtilis</italic> on production, gut health, and immunity of broiler chickens raised under suboptimal conditions</article-title><source>Poult. Sci.</source><year>2021</year><volume>100</volume><fpage>100871</fpage><pub-id pub-id-type="doi">10.1016/j.psj.2020.11.048</pub-id><?supplied-pmid 33516480?><pub-id pub-id-type="pmid">33516480</pub-id></element-citation></ref><ref id="B25-ijms-23-01168"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Opriessnig</surname><given-names>T.</given-names></name>
<name><surname>Karuppannan</surname><given-names>A.K.</given-names></name>
<name><surname>Beckler</surname><given-names>D.</given-names></name>
<name><surname>Ait-Ali</surname><given-names>T.</given-names></name>
<name><surname>Cubas-Atienzar</surname><given-names>A.</given-names></name>
<name><surname>Halbur</surname><given-names>P.G.</given-names></name>
</person-group><article-title><italic toggle="yes">Bacillus pumilus</italic> probiotic feed supplementation mitigates <italic toggle="yes">Lawsonia intracellularis</italic> shedding and lesions</article-title><source>Vet. Res.</source><year>2019</year><volume>50</volume><fpage>85</fpage><pub-id pub-id-type="doi">10.1186/s13567-019-0696-1</pub-id><?supplied-pmid 31640784?><pub-id pub-id-type="pmid">31640784</pub-id></element-citation></ref><ref id="B26-ijms-23-01168"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hlordzi</surname><given-names>V.</given-names></name>
<name><surname>Kuebutornye</surname><given-names>F.K.A.</given-names></name>
<name><surname>Afriyie</surname><given-names>G.</given-names></name>
<name><surname>Abarike</surname><given-names>E.D.</given-names></name>
<name><surname>Lu</surname><given-names>Y.</given-names></name>
<name><surname>Chi</surname><given-names>S.</given-names></name>
<name><surname>Anokyewaa</surname><given-names>M.A.</given-names></name>
</person-group><article-title>The use of <italic toggle="yes">Bacillus</italic> species in maintenance of water quality in aquaculture: A review</article-title><source>Aquac. Rep.</source><year>2020</year><volume>18</volume><fpage>100503</fpage><pub-id pub-id-type="doi">10.1016/j.aqrep.2020.100503</pub-id></element-citation></ref><ref id="B27-ijms-23-01168"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Duc</surname><given-names>L.H.</given-names></name>
<name><surname>Hong</surname><given-names>H.A.</given-names></name>
<name><surname>Barbosa</surname><given-names>T.M.</given-names></name>
<name><surname>Henriques</surname><given-names>A.O.</given-names></name>
<name><surname>Cutting</surname><given-names>S.M.</given-names></name>
</person-group><article-title>Characterization of <italic toggle="yes">Bacillus</italic> probiotics available for human use</article-title><source>Appl. Environ. Microbiol.</source><year>2004</year><volume>70</volume><fpage>2161</fpage><lpage>2171</lpage><pub-id pub-id-type="doi">10.1128/AEM.70.4.2161-2171.2004</pub-id><pub-id pub-id-type="pmid">15066809</pub-id></element-citation></ref><ref id="B28-ijms-23-01168"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>May</surname><given-names>J.J.</given-names></name>
<name><surname>Wendrich</surname><given-names>T.M.</given-names></name>
<name><surname>Marahiel</surname><given-names>M.A.</given-names></name>
</person-group><article-title>The dhb Operon of <italic toggle="yes">Bacillus subtilis</italic> Encodes the Biosynthetic Template for the Catecholic Siderophore 2,3-Dihydroxybenzoate-Glycine-Threonine Trimeric Ester Bacillibactin</article-title><source>J. Biol. Chem.</source><year>2001</year><volume>276</volume><fpage>7209</fpage><lpage>7217</lpage><pub-id pub-id-type="doi">10.1074/jbc.M009140200</pub-id><pub-id pub-id-type="pmid">11112781</pub-id></element-citation></ref><ref id="B29-ijms-23-01168"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Inaoka</surname><given-names>T.</given-names></name>
<name><surname>Takahashi</surname><given-names>K.</given-names></name>
<name><surname>Ohnishi-Kameyama</surname><given-names>M.</given-names></name>
<name><surname>Yoshida</surname><given-names>M.</given-names></name>
<name><surname>Ochi</surname><given-names>K.</given-names></name>
</person-group><article-title>Guanine Nucleotides Guanosine 5&#x02032;-Diphosphate 3&#x02032;-Diphosphate and GTP Co-operatively Regulate the Production of an Antibiotic Bacilysin in Bacillus subtilis</article-title><source>J. Biol. Chem.</source><year>2003</year><volume>278</volume><fpage>2169</fpage><lpage>2176</lpage><pub-id pub-id-type="doi">10.1074/jbc.M208722200</pub-id><pub-id pub-id-type="pmid">12372825</pub-id></element-citation></ref><ref id="B30-ijms-23-01168"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Koumoutsi</surname><given-names>A.</given-names></name>
<name><surname>Chen</surname><given-names>X.-H.</given-names></name>
<name><surname>Henne</surname><given-names>A.</given-names></name>
<name><surname>Liesegang</surname><given-names>H.</given-names></name>
<name><surname>Hitzeroth</surname><given-names>G.</given-names></name>
<name><surname>Franke</surname><given-names>P.</given-names></name>
<name><surname>Vater</surname><given-names>J.</given-names></name>
<name><surname>Borriss</surname><given-names>R.</given-names></name>
</person-group><article-title>Structural and Functional Characterization of Gene Clusters Directing Nonribosomal Synthesis of Bioactive Cyclic Lipopeptides in <italic toggle="yes">Bacillus amyloliquefaciens</italic> Strain FZB42</article-title><source>J. Bacteriol.</source><year>2004</year><volume>186</volume><fpage>1084</fpage><lpage>1096</lpage><pub-id pub-id-type="doi">10.1128/JB.186.4.1084-1096.2004</pub-id><pub-id pub-id-type="pmid">14762003</pub-id></element-citation></ref><ref id="B31-ijms-23-01168"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tsuge</surname><given-names>K.</given-names></name>
<name><surname>Ano</surname><given-names>T.</given-names></name>
<name><surname>Shoda</surname><given-names>M.</given-names></name>
</person-group><article-title>Isolation of a gene essential for biosynthesis of the lipopeptide antibiotics plipastatin B1 and surfactin in Bacillus subtilis YB8</article-title><source>Arch. Microbiol.</source><year>1996</year><volume>165</volume><fpage>243</fpage><lpage>251</lpage><pub-id pub-id-type="doi">10.1007/s002030050322</pub-id><?supplied-pmid 8639027?><pub-id pub-id-type="pmid">8639027</pub-id></element-citation></ref><ref id="B32-ijms-23-01168"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Terekhov</surname><given-names>S.S.</given-names></name>
<name><surname>Mokrushina</surname><given-names>Y.A.</given-names></name>
<name><surname>Nazarov</surname><given-names>A.S.</given-names></name>
<name><surname>Zlobin</surname><given-names>A.</given-names></name>
<name><surname>Zalevsky</surname><given-names>A.</given-names></name>
<name><surname>Bourenkov</surname><given-names>G.</given-names></name>
<name><surname>Golovin</surname><given-names>A.</given-names></name>
<name><surname>Belogurov</surname><given-names>A.</given-names></name>
<name><surname>Osterman</surname><given-names>I.A.</given-names></name>
<name><surname>Kulikova</surname><given-names>A.A.</given-names></name>
<etal/>
</person-group><article-title>A kinase bioscavenger provides antibiotic resistance by extremely tight substrate binding</article-title><source>Sci. Adv.</source><year>2020</year><volume>6</volume><fpage>eaaz9861</fpage><pub-id pub-id-type="doi">10.1126/sciadv.aaz9861</pub-id><?supplied-pmid 32637600?><pub-id pub-id-type="pmid">32637600</pub-id></element-citation></ref><ref id="B33-ijms-23-01168"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Park</surname><given-names>H.B.</given-names></name>
<name><surname>Perez</surname><given-names>C.E.</given-names></name>
<name><surname>Perry</surname><given-names>E.K.</given-names></name>
<name><surname>Crawford</surname><given-names>J.M.</given-names></name>
</person-group><article-title>Activating and Attenuating the Amicoumacin Antibiotics</article-title><source>Molecules</source><year>2016</year><volume>21</volume><elocation-id>824</elocation-id><pub-id pub-id-type="doi">10.3390/molecules21070824</pub-id></element-citation></ref><ref id="B34-ijms-23-01168"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Stohl</surname><given-names>E.A.</given-names></name>
<name><surname>Brady</surname><given-names>S.F.</given-names></name>
<name><surname>Clardy</surname><given-names>J.</given-names></name>
<name><surname>Handelsman</surname><given-names>J.</given-names></name>
</person-group><article-title>ZmaR, a Novel and Widespread Antibiotic Resistance Determinant That Acetylates Zwittermicin A</article-title><source>J. Bacteriol.</source><year>1999</year><volume>181</volume><fpage>5455</fpage><lpage>5460</lpage><pub-id pub-id-type="doi">10.1128/JB.181.17.5455-5460.1999</pub-id><?supplied-pmid 10464220?><pub-id pub-id-type="pmid">10464220</pub-id></element-citation></ref><ref id="B35-ijms-23-01168"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Polikanov</surname><given-names>Y.S.</given-names></name>
<name><surname>Osterman</surname><given-names>I.A.</given-names></name>
<name><surname>Szal</surname><given-names>T.</given-names></name>
<name><surname>Tashlitsky</surname><given-names>V.N.</given-names></name>
<name><surname>Serebryakova</surname><given-names>M.V.</given-names></name>
<name><surname>Kusochek</surname><given-names>P.</given-names></name>
<name><surname>Bulkley</surname><given-names>D.</given-names></name>
<name><surname>Malanicheva</surname><given-names>I.A.</given-names></name>
<name><surname>Efimenko</surname><given-names>T.A.</given-names></name>
<name><surname>Efremenkova</surname><given-names>O.V.</given-names></name>
<etal/>
</person-group><article-title>Amicoumacin A Inhibits Translation by Stabilizing mRNA Interaction with the Ribosome</article-title><source>Mol. Cell</source><year>2014</year><volume>56</volume><fpage>531</fpage><lpage>540</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2014.09.020</pub-id><pub-id pub-id-type="pmid">25306919</pub-id></element-citation></ref><ref id="B36-ijms-23-01168"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bankevich</surname><given-names>A.</given-names></name>
<name><surname>Nurk</surname><given-names>S.</given-names></name>
<name><surname>Antipov</surname><given-names>D.</given-names></name>
<name><surname>Gurevich</surname><given-names>A.A.</given-names></name>
<name><surname>Dvorkin</surname><given-names>M.</given-names></name>
<name><surname>Kulikov</surname><given-names>A.S.</given-names></name>
<name><surname>Lesin</surname><given-names>V.M.</given-names></name>
<name><surname>Nikolenko</surname><given-names>S.I.</given-names></name>
<name><surname>Pham</surname><given-names>S.</given-names></name>
<name><surname>Prjibelski</surname><given-names>A.D.</given-names></name>
<etal/>
</person-group><article-title>SPAdes: A new genome assembly algorithm and its applications to single-cell sequencing</article-title><source>J. Comput. Biol.</source><year>2012</year><volume>19</volume><fpage>455</fpage><lpage>477</lpage><pub-id pub-id-type="doi">10.1089/cmb.2012.0021</pub-id><?supplied-pmid 22506599?><pub-id pub-id-type="pmid">22506599</pub-id></element-citation></ref><ref id="B37-ijms-23-01168"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Seemann</surname><given-names>T.</given-names></name>
</person-group><article-title>Prokka: Rapid prokaryotic genome annotation</article-title><source>Bioinformatics</source><year>2014</year><volume>30</volume><fpage>2068</fpage><lpage>2069</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btu153</pub-id><pub-id pub-id-type="pmid">24642063</pub-id></element-citation></ref><ref id="B38-ijms-23-01168"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Blin</surname><given-names>K.</given-names></name>
<name><surname>Shaw</surname><given-names>S.</given-names></name>
<name><surname>Kloosterman</surname><given-names>A.M.</given-names></name>
<name><surname>Charlop-Powers</surname><given-names>Z.</given-names></name>
<name><surname>van Wezel</surname><given-names>G.P.</given-names></name>
<name><surname>Medema</surname><given-names>M.H.</given-names></name>
<name><surname>Weber</surname><given-names>T.</given-names></name>
</person-group><article-title>antiSMASH 6.0: Improving cluster detection and comparison capabilities</article-title><source>Nucleic Acids Res.</source><year>2021</year><volume>49</volume><fpage>W29</fpage><lpage>W35</lpage><pub-id pub-id-type="doi">10.1093/nar/gkab335</pub-id><pub-id pub-id-type="pmid">33978755</pub-id></element-citation></ref><ref id="B39-ijms-23-01168"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Medema</surname><given-names>M.H.</given-names></name>
<name><surname>Takano</surname><given-names>E.</given-names></name>
<name><surname>Breitling</surname><given-names>R.</given-names></name>
</person-group><article-title>Detecting Sequence Homology at the Gene Cluster Level with MultiGeneBlast</article-title><source>Mol. Biol. Evol.</source><year>2013</year><volume>30</volume><fpage>1218</fpage><lpage>1223</lpage><pub-id pub-id-type="doi">10.1093/molbev/mst025</pub-id><pub-id pub-id-type="pmid">23412913</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="ijms-23-01168-f001"><label>Figure 1</label><caption><p>Principal scheme of ultrahigh-throughput selection of probiotics. The wild animal is captured and the oral microbiome is isolated by non-invasive probing. Single cells of the microbiome community are coencapsulated with a reporter GFP-producing pathogen in biocompatible droplets of a microfluidic double water-in-oil-in-water emulsion. Cocultivation of a bacterial community with reporter bacteria in droplets results in two distinct populations containing bacterial cohabits and probiotic bacteria, thus mediating pathogen killing. The latter is selected by a low level of GFP fluorescence using FACS. The selected droplets are plated on agar to regenerate culturable probiotic strains. Regenerated clones are validated by coculturing assays and analyzed by activity-guided metabolomics and genomics. Detailed phenotype and genotype descriptions enable us to identify antibiotics and their biosynthetic gene clusters.</p></caption><graphic xlink:href="ijms-23-01168-g001" position="float"/></fig><fig position="float" id="ijms-23-01168-f002"><label>Figure 2</label><caption><p>Representative <italic toggle="yes">B. pumilus</italic> strains isolated from different wild hosts. (<bold>A</bold>) Summary of their origin and (<bold>B</bold>) a common set of BGCs encoding Ami, siderophore bacillibactin, and putative analogs of antimicrobials including bacilysin, class IId cyclical bacteriocin, surfactin, and desferrioxamine. Core BGC proteins and related genes (transporters, resistance, and modifying enzymes) are colored with violet and pink, respectively. Scale bar: 10 kb.</p></caption><graphic xlink:href="ijms-23-01168-g002" position="float"/></fig><fig position="float" id="ijms-23-01168-f003"><label>Figure 3</label><caption><p>Antagonistic properties of <italic toggle="yes">B. pumilus</italic> strains and Ami production. (<bold>A</bold>) Diameters of clearance zones (mm) of selected <italic toggle="yes">B. pumilus</italic> strains (D10, P1, E14, and 124) were observed for various target pathogens using agar overlay assay. <italic toggle="yes">B. subtilis</italic> 168 was used as a negative control. The (&#x02032;) symbol corresponds to diffusive clearance zones. Clearance zones were not detected for <italic toggle="yes">Acinetobacter baumanii</italic>, <italic toggle="yes">Klebsiella pneumoniae</italic>, <italic toggle="yes">Morganella morganii</italic>, <italic toggle="yes">Salmonella enterica</italic>, and <italic toggle="yes">Serratia marcenscens</italic>. Heatmap indicates the diameter value. Data represent the mean of three biological replicates &#x000b1; SD. (<bold>B</bold>) Representative agar plates with colonies of probiotic <italic toggle="yes">B. pumilus</italic> strains overlaid with <italic toggle="yes">C. koseri</italic>, <italic toggle="yes">E. faecium</italic>, <italic toggle="yes">E. coli</italic> BL21, and <italic toggle="yes">S. aureus</italic>. (<bold>C</bold>) Dynamics of Ami production by selected <italic toggle="yes">B. pumilus</italic> strains. Ami concentration (dots) was determined by HPLC and antibacterial activity assay of culture media in triplicate. * <italic toggle="yes">p</italic> &#x0003c; 0.05; ** <italic toggle="yes">p</italic> &#x0003c; 0.01. Data represent mean &#x000b1; SD.</p></caption><graphic xlink:href="ijms-23-01168-g003" position="float"/></fig><fig position="float" id="ijms-23-01168-f004"><label>Figure 4</label><caption><p>Antimicrobial activity landscapes of <italic toggle="yes">B. pumilus</italic> D10. Reporter <italic toggle="yes">S. aureus</italic> (<bold>A</bold>,<bold>B</bold>) and <italic toggle="yes">E. coli</italic> (<bold>C</bold>,<bold>D</bold>) were cocultivated with effector strains using various cell ratios. Effector <italic toggle="yes">B. subtilis</italic> 168 strain was used as a negative control. Target was analyzed by fluorescence of culture after 24 h of cocultivation. Heatmap indicates maximal target proliferation estimated by relative fluorescence level.</p></caption><graphic xlink:href="ijms-23-01168-g004" position="float"/></fig><fig position="float" id="ijms-23-01168-f005"><label>Figure 5</label><caption><p>Biodiversity of Ami clusters. (<bold>A</bold>) A phylogenetic tree of Ami clusters was built based on the key hybrid PKS/NRPS enzyme AmiI homology. BGCs encoding Ami (<italic toggle="yes">B. pumilus</italic> type, <italic toggle="yes">B. subtilis</italic> type, <italic toggle="yes">Paludifilum</italic> type, and <italic toggle="yes">Paenibacillus</italic> type) are colored with warm colors (yellow, orange, and red). BGCs encoding zwittermicin A (ZmA) are colored with cold colors (sapphire and violet for <italic toggle="yes">B. thuringiensis</italic> type and <italic toggle="yes">B. cereus</italic> type, respectively). (<bold>B</bold>) Protein identity and protein cover of AmiI homologs. Ami cluster family and ZmA cluster family are highlighted with a dotted line. (<bold>C</bold>) Comparative analysis of the architecture of Ami clusters and ZmA clusters and (<bold>D</bold>) their biosynthetic products. Core Ami enzymes are colored with orange. ZmA cluster is colored with violet. AmiI in Ami cluster and its homolog ZmaK in ZmA cluster are subscribed and their biosynthetic fragments are highlighted with orange and violet in Ami and ZmA structures, respectively. Transporter AmiP is colored with green. Kinase AmiN and phosphatase AmiO mediate self-resistance toward Ami and Ami activation, respectively. AmiN and AmiO are colored with aquamarine. <italic toggle="yes">Paenibacillus</italic> genes encoding proteins putatively associated with transport/self-resistance are colored with red.</p></caption><graphic xlink:href="ijms-23-01168-g005" position="float"/></fig></floats-group></article>